Medicine administration kit, percutaneous, medicated, single-use
Australia TGA ARTG Registered Device · Bayer Australia Ltd · Bayer AG · Class IIa · Started September 11, 2008
Good Name: Bayer Australia Limited - Medicine administration kit, percutaneous, medicated, single-use
- Risk Class
- Class IIa
- Product Type
- Procedure Pack
- ARTG Category
- General
- Start Date
- September 11, 2008
- Effective Date
- September 11, 2008
- Name
- Bayer AG
- Country
- Germany
- Address
- Mullerstrasse 178, Berlin, 13353
A collection of devices to enable percutanous administration of Betaferon (Interferon beta-1b) ARTG 83309
Access comprehensive regulatory information for Medicine administration kit, percutaneous, medicated, single-use in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Bayer Australia Ltd, manufactured by Bayer AG in Germany. The device registration started on September 11, 2008.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.